Advanced search
Publication Cover
mAbs Volume 8, 2016 - Issue 1
Submit an article Journal homepage
4,835
Views
12
CrossRef citations to date
0
Altmetric
Perspective

Intellectual property issues of immune checkpoint inhibitors

Ulrich StorzSenior Partner, Michalski; Hüttermann Patent Attorneys; Düsseldorf, GermanyCorrespondence[email protected]
Pages 10-26 | Received 21 Sep 2015, Accepted 08 Oct 2015, Published online: 23 Nov 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xiangjun Kong, Qianru Zhang, Yunfeng Lai, Hao Hu, Xin Chen & Yuanjia Hu. (2018) Global patent landscape of programmed cell death 1: implications of the rapid expansion. Expert Opinion on Therapeutic Patents 28:1, pages 69-80.
Read now
Chia-Lin Pan & Feng-Chi Chen. (2017) Patent trend and competitive analysis of cancer immunotherapy in the United States. Human Vaccines & Immunotherapeutics 13:11, pages 2583-2593.
Read now
Matthieu Collin. (2016) Immune checkpoint inhibitors: a patent review (2010-2015). Expert Opinion on Therapeutic Patents 26:5, pages 555-564.
Read now

Articles from other publishers (9)

Andrew H. Miller & Charles L. Raison. (2023) Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure. Molecular Psychiatry 28:8, pages 3167-3168.
Crossref
Sara Ravasio. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy 327 347 .
Michael Bernardes Ramos, Anna Erika Vieira de Araújo, Cristiane Pinheiro Pestana, Ana Paula Dinis Ano Bom, Renata Chagas Bastos, Aline de Almeida Oliveira, Patrícia Cristina da Costa Neves & Haroldo Cid da Silva Junior. (2020) Initial development of biosimilar immune checkpoint blockers using HEK293 cells. Protein Expression and Purification 170, pages 105596.
Crossref
Ulrich Storz. (2019) The nine lives of epitope-based antibody patents. Human Antibodies, pages 1-22.
Crossref
Philippe Serrano, Markus Hartmann, Elmar Schmitt, Pedro Franco, Georgios Amexis, Jan Gross & Christine Mayer‐Nicolai. (2018) Clinical Development and Initial Approval of Novel Immune Checkpoint Inhibitors in Oncology: Insights From a Global Regulatory Perspective. Clinical Pharmacology & Therapeutics 105:3, pages 582-597.
Crossref
Lara V. Marks. 2017. Engineering Health: How Biotechnology Changed Medicine. Engineering Health: How Biotechnology Changed Medicine 97 125 .
Matthieu Collin. (2017) Immune checkpoint inhibitors: the battle of giants. Pharmaceutical Patent Analyst 6:4, pages 137-139.
Crossref
Ulrich Storz. (2017) Of patents and patent disputes: The TNFα patent files. Part 1: Humira. Human Antibodies 25:1-2, pages 1-16.
Crossref
Hua Cai. (2016) The Analysis of Intellectual Property Issues and Countermeasures. The Analysis of Intellectual Property Issues and Countermeasures.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.